#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

PL_starsi_muz_oko_kapky

Antiglaucoma Eye Drops with Preservatives – Higher Likelihood of Glaucoma Surgery?

18. 2. 2021 Source: Treatment of Glaucoma

A recently published French study sought to answer the question of whether there is a connection between the presence of preservatives in antiglaucoma eye drops and the probability of undergoing glaucoma surgery.

PL_CT_lekar_zprava

Quantitative CT as a New Tool for Evaluating COPD in Alpha-1 Antitrypsin Deficiency

For such a rare hereditary disorder as alpha-1 antitrypsin deficiency (AATD), we have so far used…
18. 2. 2021 Source: Deficiency of Alpha-1-Antitrypsin
léky_lékař

Intravenous Thrombolysis in Ischemic Stroke Patients on Dabigatran Treatment

What are the outcomes of performing intravenous thrombolysis in patients with acute ischemic stroke…
18. 2. 2021 Source: Anticoagulant Treatment
Lactobacillus reuteri

Lactobacillus reuteri − a natural probiotic with lifelong significance

Probiotics are often given to newborns within the first few days of life to alleviate infantile…
16. 2. 2021 Source: GI, colic and microbiome
PL_covid_zazivani_bricho_prujem_trakt_muz

State of the Intestinal Microbiome and COVID-19 Infection − Possible Correlations

Some patients infected with the SARS-CoV-2 virus exhibit gastrointestinal symptoms, including…
16. 2. 2021 Source: GI, colic and microbiome
Transfuze_krevni_banka

Safety Profile of Antiemetic Therapy in Patients Preparing for Hematopoietic Stem Cell Transplantation

An observational study conducted at a university clinic in Barcelona investigated the safety of the…
15. 2. 2021 Source: Antiemetic Therapy
Zvracení_nevolnot_žena_toaleta

Intravenous Fixed Combination NEPA in the Prevention of Chemotherapy-Induced Vomiting

Summary data from several studies were used by the authors of the following analysis to evaluate…
15. 2. 2021 Source: Antiemetic Therapy
Plíce_snímek_lékař_pacient

Brigatinib vs. Crizotinib in the Treatment of ALK-Positive NSCLC – Results of the Second Interim Analysis of the ALTA-1L Study

The anaplastic lymphoma kinase inhibitor brigatinib demonstrated superiority over crizotinib in the…
15. 2. 2021 Source: Non-Small Cell Lung Cancer
Plíce_snímek_tablet_lékaři

Good Efficacy of Brigatinib After Failure of 2nd Generation ALK Inhibitors

Brigatinib is commonly used in the treatment of ALK-positive non-small cell lung cancer (NSCLC) in…
15. 2. 2021 Source: Non-Small Cell Lung Cancer
prohlídka lékař pacient nemocnice medicína vyšetření pomoc ruce

Does olaparib improve overall survival in patients with recurrent ovarian cancer and BRCA mutation?

Olaparib, a poly(ADP-ribose) polymerase (PARP) enzyme inhibitor, in tablet form is indicated, among…
13. 2. 2021 Source: Ovarian and Breast Cancer
1 115 116 117 118 119 162
Filter by speciality
Remove filters

Conferences

News from the world of medicine

11. 6.
Konference POROD 2025

25. 9.
XIX. Pediatrický kongres s mezinárodní účastí

All conferences
Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#